Pulmonology/Critical Care

ATS 2013

New research is being presented at ATS 2013, the American Thoracic Society International Conference, from May 17-22 in Philadelphia. Meeting Highlights Identifying Depression Risk in COPD Patients Sleep Apnea & Glucose...

Read More

Breo Ellipta Approved to Treat COPD

The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic...

Read More